Parasite Burden in Hamsters Infected with Two Different Strains of Leishmania (Leishmania) infantum: "Leishman Donovan Units" versus Real-Time PCR

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Moreira, Nádia das Dores ^a   Vitoriano Souza, Juliana ^a   Roatt, Bruno Mendes ^a   Vieira, Paula Melo de Abreu ^a   Ker, Henrique Gama ^a   de Oliveira Cardoso, Jamille Mirelle ^a   Giunchetti, Rodolfo Cordeiro ^a   Carneiro, Cláudia Martins ^a   de Lana, Marta ^a   Reis, Alexandre Barbosa ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; LEISHMANIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FOLLOW UP; GENETIC STRAIN; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPROPHYLAXIS; INOCULATION; LEISHMAN DONOVAN UNIT; LEISHMANIA INFANTUM; LIVER; MALE; METHODOLOGY; MICROBIOLOGICAL PARAMETERS; MORTALITY; NONHUMAN; PARASITE LOAD; PARASITISM; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPLEEN; SURVIVAL; SYRIAN HAMSTER; VISCERAL LEISHMANIASIS; WILD TYPE;

ANIMALS; CRICETINAE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIVER; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN;

ANIMALIA; CRICETINAE; LEISHMANIA INFANTUM; MESOCRICETUS AURATUS;

EID: 84868148374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047907     Document Type: Article

References (53)

1. WHO (2010) Working to overcome the global impact of neglected tropical diseases. First WHO reported on neglected tropical diseases. In WHO Geneva 184.
2. Desjeux P, (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
3. Piscopo TV, Mallia Azzopardi C, (2007) Leishmaniasis. Postgrad Med J 83: 649-657.
4. Handman E, (2001) Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 14: 229-243.
5. Hommel M, Jaffe CL, Travi B, Milon G, (1995) Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann Trop Med Parasitol 89Suppl 1: 55-73.
6. Melby PC, Chandrasekar B, Zhao W, Coe JE, (2001) The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol 166: 1912-1920.
7. Requena JM, Soto M, Doria MD, Alonso C, (2000) Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet Immunol Immunopathol 76: 269-281.
8. Carrion J, Nieto A, Iborra S, Iniesta V, Soto M, et al. (2006) Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol 28: 173-183.
9. Nieto A, Dominguez-Bernal G, Orden JA, De La Fuente R, Madrid-Elena N, et al. (2011) Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model. Vet Res 42: 39.
10. Bunn-Moreno MM, Madeira ED, Miller K, Menezes JA, Campos-Neto A, (1985) Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Clin Exp Immunol 59: 427-434.
11. Gifawesen C, Farrell JP, (1989) Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect Immun 57: 3091-3096.
12. Mathias R, Costa FA, Goto H, (2001) Detection of immunoglobulin G in the lung and liver of hamsters with visceral leishmaniasis. Braz J Med Biol Res 34: 539-543.
13. Fruth U, Solioz N, Louis JA, (1993) Leishmania major interferes with antigen presentation by infected macrophages. J Immunol 150: 1857-1864.
14. Rodrigues V Jr, Santana da Silva J, Campos-Neto A, (1998) Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. Infect Immun 66: 1233-1236.
15. Vasconcellos RC, Urago KP, Bunn-Moreno MM, Madeira ED, (1996) Suppressor activity in Leishmania donovani-infected hamster serum: reversion by delipidated bovine serum albumin and role in cell cycle events. Braz J Med Biol Res 29: 615-622.
16. Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW, (1994) Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 62: 1058-1063.
17. Rolao N, Cortes S, Gomes-Pereira S, Campino L, (2007) Leishmania infantum: mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice. Exp Parasitol 115: 270-276.
18. Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, et al. (2008) Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A 105: 7845-7850.
19. Stauber L (1955) Leishmaniasis in the hamster. In "Some Physiological Aspects and Consequences of Parasitism," (W. H. Cole, ed.), Rutgers University Press, New Brunswisck, New Jersey, 76-90.
20. Poot J SS, Daland C, Herrman, Eva M, Kuhn, Arno N (2006) Optimization of a Leishmania infantum challenge model in hamster. Intervet International BV 57-70.
21. Rica-Capela MJ, Cortes S, Leandro C, Peleteiro MC, Santos-Gomes G, et al. (2003) Immunological and histopathological studies in a rodent model infected with Leishmania infantum promastigotes or amastigotes. Parasitol Res 89: 163-169.
22. Dea-Ayuela MA, Rama-Iniguez S, Alunda JM, Bolas-Fernandez F, (2007) Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds. Vet Res Commun 31: 703-717.
23. Bretagne S, Durand R, Olivi M, Garin JF, Sulahian A, et al. (2001) Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol 8: 828-831.
24. Manna L, Gravino AE, Picillo E, Decaro N, Buonavoglia C, (2008) Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine. Ann N Y Acad Sci 1149: 358-360.
25. Coura-Vital W, Marques MJ, Veloso VM, Roatt BM, Aguiar-Soares RD, et al. (2011) Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods. PLoS Negl Trop Dis 5: e1291.
26. Degrave W, Fernandes O, Campbell D, Bozza M, Lopes U, (1994) Use of molecular probes and PCR for detection and typing of Leishmania-a mini-review. Mem Inst Oswaldo Cruz 89: 463-469.
27. Volpini AC, Passos VM, Oliveira GC, Romanha AJ, (2004) PCR-RFLP to identify Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis causing American cutaneous leishmaniasis. Acta Trop 90: 31-37.
28. Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, et al. (2006) Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Vet Immunol Immunopathol 112: 102-116.
29. Evans TG, Smith D, Pearson RD, (1990) Humoral factors and nonspecific immune suppression in Syrian hamsters infected with Leishmania donovani. J Parasitol 76: 212-217.
30. Gupta S, Sane SA, Shakya N, Vishwakarma P, Haq W, (2011) CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis. Antimicrob Agents Chemother 55: 3461-3464.
31. Gupta R, Kushawaha PK, Samant M, Jaiswal AK, Baharia RK, et al. (2012) Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses. J Antimicrob Chemother 67: 440-443.
32. Carrion J, Folgueira C, Soto M, Fresno M, Requena JM, (2011) Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation. Parasit Vectors 4: 150.
33. da Silva RA, Tavares NM, Costa D, Pitombo M, Barbosa L, et al. (2011) DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis. Acta Trop 120: 185-190.
34. Masih S, Arora SK, Vasishta RK, (2011) Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis. Exp Parasitol 129: 55-64.
35. Pulido SA, Munoz DL, Restrepo AM, Mesa CV, Alzate JF, et al. (2012) Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs. Acta Trop 122: 36-45.
36. Reimao JQ, Colombo FA, Pereira-Chioccola VL, Tempone AG, (2012) Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Exp Parasitol 130: 195-199.
37. Prajapati VK, Awasthi K, Yadav TP, Rai M, Srivastava ON, et al. (2012) An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis. J Infect Dis 205: 333-336.
38. Kushawaha PK, Gupta R, Tripathi CD, Sundar S, Dube A, (2012) Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis. PLoS One 7: e35670.
39. Tupperwar N, Vineeth V, Rath S, Vaidya T, (2008) Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen. Diagn Microbiol Infect Dis 61: 23-30.
40. da Silva RN, Amorim AC, Brandao RM, de Andrade HM, Yokoo M, et al. (2010) Real-time PCR in clinical practice: a powerful tool for evaluating Leishmania chagasi loads in naturally infected dogs. Ann Trop Med Parasitol 104: 137-143.
41. Mary C, Faraut F, Lascombe L, Dumon H, (2004) Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42: 5249-5255.
42. Quaresma PF, Murta SM, Ferreira Ede C, da Rocha-Lima AC, Xavier AA, et al. (2009) Molecular diagnosis of canine visceral leishmaniasis: identification of Leishmania species by PCR-RFLP and quantification of parasite DNA by real-time PCR. Acta Trop 111: 289-294.
43. Verma S, Kumar R, Katara GK, Singh LC, Negi NS, et al. (2010) Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One 5: e10107.
44. Galai Y, Chabchoub N, Ben-Abid M, Ben-Abda I, Ben-Alaya-Bouafif N, et al. (2011) Diagnosis of mediterranean visceral leishmaniasis by detection of Leishmania antibodies and Leishmania DNA in oral fluid samples collected using an Oracol device. J Clin Microbiol 49: 3150-3153.
45. Sudarshan M, Weirather JL, Wilson ME, Sundar S, (2011) Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis. J Antimicrob Chemother 66: 1751-1755.
46. Cikos S, Bukovska A, Koppel J, (2007) Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol 8: 113.
47. Ott KJ, Hanson WL, Stauber LA, (1967) Course of infection of Leishmania donovani in hamsters inoculated by the intraperitoneal route. J Parasitol 53: 641-645.
48. Binhazim AA, Chapman WL Jr, Shin SS, Hanson WL, (1993) Determination of virulence and pathogenesis of a canine strain of Leishmania Leishmania infantum in hamsters and dogs. Am J Vet Res 54: 113-121.
49. Melby PC, Tryon VV, Chandrasekar B, Freeman GL, (1998) Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis. Infect Immun 66: 2135-2142.
50. Kaye PM, Svensson M, Ato M, Maroof A, Polley R, et al. (2004) The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201: 239-253.
51. Garg R, Dube A, (2006) Animal models for vaccine studies for visceral leishmaniasis. Indian J Med Res 123: 439-454.
52. Wilson ME, Innes DJ, Sousa AD, Pearson RD, (1987) Early histopathology of experimental infection with Leishmania donovani in hamsters. J Parasitol 73: 55-63.
53. Paranhos-Silva M, Oliviera GGS, Reis EA, de Menezes RMC, Fernandes O, et al. (2003) A follow-up of Beagle dogs intradermally infected with Leishmania chagasi in the presence or absence of sand fly saliva. Veterinary Parasitology 114: 97-111.